The American holding Johnson & Johnson specializes in the manufacture of healthcare and hygiene products. It ranks first in the world's top of companies with the largest output of medical equipment. Founded in 1886 as a family business, the company was initially engaged in the manufacture of bandaging products. The shares were put up for sale in 1944, shortly after, a thriving corporation set after swallowing up its European and North American competitors. The Company aims for the transition to the environmentally-clean manufacturing. To achieve this, a number of factories have switched to solar energy. Moreover, Johnson & Johnson avoid using plastic packaging for liquid products wherever possible. The medical specialization of the holding still stands for oncology, immunology, infectious diseases, neurology, and psychiatry. Johnson & Johnson actively invests in these areas' development. The company's current capitalization hits $317 billion. The Johnson & Johnson corporation is comprised of over 250 companies; it owns rights to over 120 brands. Alex Gorski is the Company's Director General since 2012. At the beginning of the Noughties, he was working for the Company's rivals for a while, but afterward, he returned and was rather speedily promoted. The General Director's power is not absolute; in fact, the extended holding is managed by the Board of the Company. Shares of Johnson & Johnson are rated as stable, growing in value slowly but steadily though.
Nyní budete vždy vědět, do kterých akcií je výhodnější investovat